Image of DMD patient with caregiver

For patients living with Duchenne muscular dystrophy, early, long-term treatment can

Help him create his own story

EMFLAZA® is indicated for the treatment of Duchenne muscular dystrophy in patients 5 years of age and older.

see how emflaza can help
DMD Patient

See how Duchenne affects your child

Duchenne is a rare, progressive disease that causes muscles to weaken over time.1 Learning more about DMD can help empower you to remain hopeful as you navigate this life-changing diagnosis.

continue learning
Image of flying a toy plane

EMFLAZA IS TAKEN JUST ONCE A DAY

EMFLAZA® (deflazacort) is available as a tablet or in liquid form and can be taken once a day, with or without food.2

get more dosing information
image of caregiver with tablet

WE CAN HELP YOU START YOUR EMFLAZA CHAPTER

PTC Cares is a support program dedicated to helping you understand the prescription process, financial assistance, and insurance information.

see how we can help
icon of a form

complete the first step toward getting emflaza

The Prescription Start Form serves as a prescription as well as a consent to receive support from PTC Cares and PTC products. Print the form and complete it with the help of your healthcare provider.

Image of caregiver and patient

WE WANT TO HELP KEEP YOU CONNECTED

You can receive useful emails with additional information about Duchenne and EMFLAZA treatment. Just register your email and we will share updates as they become available.

sign up today
icon of discussion

FIND YOUR DMD COMMUNITY

Expand your support system by exploring this caring community of families, healthcare providers, and Duchenne advocates. They're available to help you and your family.

icon of paper

EXPLORE THE PATIENT RESOURCE LIBRARY

There are a wide array of resources available to help you learn more about life with Duchenne. Visit the Patient Resource Library to access these materials, including the Prescription Start Form.

1. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9(1):77-93. 2. EMFLAZA (deflazacort) (package insert). South Plainfield, NJ: PTC Therapeutics, Inc.